Login / Signup

Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study.

Christine M DurandBrittany BarnabaSile YuDiane M BrownMichael A ChattergoonNichole BairFizza F NaqviMark S SulkowskiDorry L SegevNiraj M Desai
Published in: Annals of internal medicine (2020)
Keyphrases
  • kidney transplantation
  • randomized controlled trial
  • clinical trial